跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sernade - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Sernade
Approved
STANDARD
Sernade
PT Novell Pharmaceutical Laboratories
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0839dc4b8956fc7e
Company
PT Novell Pharmaceutical Laboratories
Type
Standard
Approval Details
Approval Id
0839dc4b8956fc7e
Drug Approval Philippines Name
Sernade
Product Name
Sernade
Registration Number
DR-XY37372
Brand Name
Sernade
Generic Name
Sertraline (as Hydrochloride)
Dosage Form
Film Coated Tablet
Dosage Strength
50 mg
Manufacturer
PT Novell Pharmaceutical Laboratories
Importer
Prosweal Healthcare Inc.
Distributor
Prosweal Healthcare Inc.
Company Detail Path
/organization/pt-novell-pharmaceutical-laboratories
Issuance Date
13 October 2024
Expiry Date
21 January 2030
Pharmacologic Category
Antidepressant (Selective Serotonin Reuptake Inhibitor)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0839dc4b8956fc7e
Type
Standard
Back to Philippines FDA Approvals